Assessing the Safety of Stem Cell Therapeutics
Christopher E. Goldring(University of Liverpool), B. Kevin Park(University of Liverpool), Lorna Kelly(University of Liverpool), Nissim Benvenisty(Hebrew University of Jerusalem), Deborah Ladenheim(Athersys (United States)), Uri Ben‐David(Tel Aviv University), Rowena Eakins(University of Liverpool), Annamaria Rossi, Paul Duffy(United States Geological Survey), Peter W. Andrews(University of Sheffield), Michaela Sharpe(Pfizer (United Kingdom)), Neil French(University of Liverpool), Jens Kurth(Novartis (Switzerland)), Sara Patel(ReNeuron (United Kingdom)), Jens Reinhardt(Paul Ehrlich Institut), Hugh Laverty(University of Liverpool), Gopalan Narayanan, James W. McBlane, Neil R. Kitteringham(University of Liverpool), Neil A. Hanley(Manchester Academic Health Science Centre)
Cited by 253
Related Papers
Differentiation of Human Embryonic Stem Cells into Embryoid Bodies Comprising the Three Embryonic Germ Layers
|Molecular Medicine|2000|1.5k
Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells
|Proceedings of the National Academy of Sciences|2000|1.1k
The tumorigenicity of human embryonic and induced pluripotent stem cells
|Nature reviews. Cancer|2011|886
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
|Nature Cancer|2020|880